缩写名/全名 |
BONE MARROW TRANSPL
BONE MARROW TRANSPLANTATION |
||||||||||||||||||||
ISSN号 | 0268-3369 | ||||||||||||||||||||
研究方向 | 医学-免疫学 | ||||||||||||||||||||
影响因子 | 2015:3.636, 2016:3.874, 2017:4.497, 2018:4.674, 2019:4.725, | ||||||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||||||
出版周期 | Semimonthly | ||||||||||||||||||||
年文章数 | 215 | ||||||||||||||||||||
出版年份 | 1986 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 一般,3-8周 |
||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||
投稿链接 | http://mts-bmt.nature.com/cgi-bin/main.plex | ||||||||||||||||||||
投稿官网 | http://www.nature.com/bmt/index.html | ||||||||||||||||||||
h-index | 119 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0268-3369%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes. Author: Tang S1,2, Shen H1,3,4, Qu C1,3,4, Dai H1,3,4, Zhu X1,3,4, Xue S1,3,4, Ding Z1,3,4, Lu J1,3,4, Wu D5,6,7, Tang X8,9,10. Journal: Bone Marrow Transplant. 2019 Feb;54(2):236-243. doi: 10.1038/s41409-018-0249-7. Epub 2018 Jun 25. PubMed DOI |
2. | Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis. Author: Yang B1, Yu R2, Cai L3, Bin Guo4, Chen H1,5, Zhang H6, He P7, Lu X8. Journal: Bone Marrow Transplant. 2019 Jan;54(1):99-122. doi: 10.1038/s41409-018-0239-9. Epub 2018 Jul 9. PubMed DOI |
3. | Clinical outcome of FLAG-IDA chemotherapy sequential with Flu-Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes. Author: Wang L1, Devillier R2, Wan M3, Decroocq J2, Tian L3, Fürst S2, Wang LN1, Vey N2, Fan X1, Blaise D4, Hu J5. Journal: Bone Marrow Transplant. 2019 Mar;54(3):458-464. doi: 10.1038/s41409-018-0283-5. Epub 2018 Aug 6. PubMed DOI |
4. | The significance of peri-transplantation minimal residual disease assessed by multiparameter flow cytometry on outcomes for adult AML patients receiving haploidentical allografts. Author: Liu J1, Ma R1, Liu YR1, Xu LP1, Zhang XH1, Chen H1, Chen YH1, Wang FR1, Han W1, Sun YQ1, Yan CH1, Tang FF1, Mo XD1, Liu KY1, Fan QZ1, Huang XJ1,2,3, Chang YJ4,5. Journal: Bone Marrow Transplant. 2019 Apr;54(4):567-577. doi: 10.1038/s41409-018-0300-8. Epub 2018 Aug 20. PubMed DOI |
5. | Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation. Author: Ciurea SO1, Cao K2, Fernandez-Vina M3, Kongtim P4, Malki MA5, Fuchs E6, Luznik L6, Huang XJ7, Ciceri F8, Locatelli F9, Aversa F10, Castagna L11, Bacigalupo A12, Martelli M13, Blaise D14, Handgretinger R15, Roy DC16, O'Donnell P17, Bashey A18, Lazarus HM19, Ballen K20, Savani BN21, Mohty M22, Nagler A23,24. Journal: Bone Marrow Transplant. 2019 May;54(5):784. doi: 10.1038/s41409-018-0332-0. PubMed DOI |
6. | Challenges in managing graft-versus-host disease in developing countries: a perspective. Author: Saleem MS1, Aljurf M2, Srivastava A3, Shamsi T4, Lu PH5, Hamidieh AA6, El Haddad A7, Hashmi SK8,9. Journal: Bone Marrow Transplant. 2019 May;54(5):641-647. doi: 10.1038/s41409-018-0333-z. Epub 2018 Sep 20. PubMed DOI |
7. | Successful treatment of two relapsed/refractory t(8;21) acute myeloid leukemia patients by CD19-directed chimeric antigen receptor T cells. Author: Qu C1,2,3, Li Z1,2,3, Kang L4,5, Wang Y6, Dai H1,2,3, Yin J1,2,3, Chen G1,2,3, Zhu M1,2,3, Yao L1,2,3, Xu T1,2,3, Tian X1,2,3, Xu Y1,2,3, Chen J1,2,3, Zhu X1,2,3, Yu L4,5, Wu D1,2,3, Tang X7,8,9. Journal: Bone Marrow Transplant. 2019 Jan 10. doi: 10.1038/s41409-018-0423-y. [Epub ahead of print] PubMed DOI |
8. | Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors. Author: Lv M1, Zhai SZ1, Wang Y1, Xu LP1, Zhang XH1, Chen H1, Chen YH1, Wang FR1, Han W1, Sun YQ1, Cheng YF1, Yan CH1, Mo XD1, Liu KY1, Chang YJ1, Huang XJ1,2, Zhao XY3. Journal: Bone Marrow Transplant. 2019 Jan 17. doi: 10.1038/s41409-018-0427-7. [Epub ahead of print] PubMed DOI |
9. | Central nervous system complications caused by 3-4 grade aGVHD in adult patients occurred in HLA-mismatched recipients majorly after allogeneic hematopoietic stem cell transplantation. Author: Ke P1, Bao X2, Qiu H2, Zhuang J2, Hu X2, Wu X2, Liu Y2, Wu D2, Xue S2, Zhang X3, Ma X4. Journal: Bone Marrow Transplant. 2019 Jan 21. doi: 10.1038/s41409-019-0443-2. [Epub ahead of print] PubMed DOI |
10. | Eltrombopag is an effective and safe therapy for refractory thrombocytopenia after haploidentical hematopoietic stem cell transplantation. Author: Fu H1,2, Zhang X1,2, Han T1,2, Mo X1,2, Wang Y1,2, Chen H1,2, Han W1,2, Wang J1,2, Wang F1,2, Yan C1,2, Zhang Y1,2, Sun Y1,2, Liu K1,2, Huang X1,2,3,4, Xu L5,6. Journal: Bone Marrow Transplant. 2019 Jan 21. doi: 10.1038/s41409-019-0435-2. [Epub ahead of print] PubMed DOI |
|
|